Your browser doesn't support javascript.
loading
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination.
Merlini, Alessandra; Centomo, Maria Laura; Ferrero, Giulio; Chiabotto, Giulia; Miglio, Umberto; Berrino, Enrico; Giordano, Giorgia; Brusco, Silvia; Pisacane, Alberto; Maldi, Elena; Sarotto, Ivana; Capozzi, Federica; Lano, Cristina; Isella, Claudio; Crisafulli, Giovanni; Aglietta, Massimo; Dei Tos, Angelo Paolo; Sbaraglia, Marta; Sangiolo, Dario; D'Ambrosio, Lorenzo; Bardelli, Alberto; Pignochino, Ymera; Grignani, Giovanni.
Affiliation
  • Merlini A; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Centomo ML; Department of Oncology, University of Torino, Turin, Italy.
  • Ferrero G; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Chiabotto G; Department of Oncology, University of Torino, Turin, Italy.
  • Miglio U; Department of Clinical and Biological Sciences, University of Torino, Turin, Italy.
  • Berrino E; Department of Computer Science, University of Torino, Turin, Italy.
  • Giordano G; Department of Medical Sciences, University of Torino, Turin, Italy.
  • Brusco S; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Pisacane A; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Maldi E; Department of Medical Sciences, University of Torino, Turin, Italy.
  • Sarotto I; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Capozzi F; Department of Oncology, University of Torino, Turin, Italy.
  • Lano C; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Isella C; Department of Oncology, University of Torino, Turin, Italy.
  • Crisafulli G; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Aglietta M; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Dei Tos AP; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Sbaraglia M; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Sangiolo D; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • D'Ambrosio L; Department of Oncology, University of Torino, Turin, Italy.
  • Bardelli A; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Pignochino Y; Department of Oncology, University of Torino, Turin, Italy.
  • Grignani G; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
Front Oncol ; 12: 844250, 2022.
Article in En | MEDLINE | ID: mdl-36110934
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article